ECSP993197A - AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC) - Google Patents

AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Info

Publication number
ECSP993197A
ECSP993197A ECSP993197A ECSP993197A EC SP993197 A ECSP993197 A EC SP993197A EC SP993197 A ECSP993197 A EC SP993197A EC SP993197 A ECSP993197 A EC SP993197A
Authority
EC
Ecuador
Prior art keywords
lea
case
oral administration
drug formulation
aqueous drug
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hans-Martin Siefert
Tobias Laich
Annette Simon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993197 priority Critical patent/ECSP993197A/en
Publication of ECSP993197A publication Critical patent/ECSP993197A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica acuosa para uso oral que comprende un principio activo de la clase de los antibióticos ácidos quinolón o naftiridoncarboxilicos asi como al menos un ácido policarboxílico o una sal del mismo expandibles, a un procediento para su preparación asi como al uso de la misma para la fabricación de un medicamento.The present invention relates to an aqueous pharmaceutical composition for oral use comprising an active ingredient from the class of quinolone or naphthyridonecarboxylic acid antibiotics as well as at least one expandable polycarboxylic acid or salt thereof, to a process for its preparation as well as to the use of the same for the manufacture of a medicine.

ECSP993197 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC) ECSP993197A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Publications (1)

Publication Number Publication Date
ECSP993197A true ECSP993197A (en) 2000-01-27

Family

ID=42044186

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Country Status (1)

Country Link
EC (1) ECSP993197A (en)

Similar Documents

Publication Publication Date Title
ATE235895T1 (en) DRUG DELIVERY SYSTEM CONTAINING A HARD-PACKED, SOLID DRUG BASE
NZ631100A (en) Soft chewable pharmaceutical products
AR006678A1 (en) DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
MX2010004222A (en) Solid formulations of crystalline compounds.
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
NO20080827L (en) Solid dosage formulations of narcotic drugs that have improved buccal adsorption
BRPI0611400B8 (en) Muco-adhesive xyloglycan-containing formulations useful in medical devices and pharmaceutical formulations
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
CO5060477A1 (en) DOSAGE FORM OF NEFAZODONA
NO20080220L (en) Formulations with high drug loading and dosage forms
BR0312563A (en) Lasofoxifene tablet and its coating
CO5640037A2 (en) DERIVATIVES OF QUINAZOLINE FOR THE TREATMENT OF CANCER
DE60313359D1 (en) FENOFIBRATEDIC PHARMACEUTICAL COMPOSITION AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS AND DERIVATIVES
CY1118057T1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
AR044200A1 (en) COMPOSITION OF FONDAPARINUX SODICO DE HIGH PURITY, A PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT AS AN ACTIVE PRINCIPLE
UY29561A1 (en) DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
AR013967A1 (en) A DRUG FORMULATION FOR ORAL ADMINISTRATION OF CONTROLLED PELLET PELLET THAT HAS CONTROLLED RELEASE OF AN ACTIVE COMPOUND THAT IS SELECTED FROM THE ACID 1-CYCLOPROPIL-7- [(S, S) -2,8-DIAZABICICLO [4.3.0] NON- 8-IL] -6-FLUOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-CARBOXILIC QUINOLON OR SALE
HRP20050342B1 (en) OLANZAPINE PHARMACEUTICAL FORMULATION
DE50006842D1 (en) 4-BENZYLAMINOCHINOLINE CONJUGATES WITH GALLIC ACID AND THEIR HETEROANALOGS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND THE USE THEREOF
AR024411A1 (en) POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT-3-ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
ECSP993197A (en) AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)
TR200601092T1 (en) New oral pharmaceutical formulations containing the active ingredient irbesartan.
HN1999000174A (en) ACUISA MEDICATION FORMULATION FOR ORAL ADMINISTRATION.
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION